News & Updates

DEA Changes Emergency CII Requirements

Apr 1, 2020 Tags:

Dear Practitioner Registrants and Pharmacists:

The Drug Enforcement Administration (DEA) is providing the following guidance regarding the issuance of oral schedule II prescriptions in light of the nationwide public health emergency (“Public Health Emergency”) declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, pursuant to section 319 of the Public Health and Service Act, 42 U.S.C. 247d, as a result of the Coronavirus Disease 2019 (COVID-19). The term “oral schedule II prescription” means a prescription for a schedule II controlled substance that a practitioner conveys to a pharmacist via a telephone call or other oral form of communication – as opposed to via a written or electronic prescription. DEA is aware that during this pandemic there are obstacles to practitioners meeting with their existing patients and providing these patients with written prescriptions for schedule II controlled substances. As a result, practitioners and pharmacists have asked DEA to clarify the circumstances under which oral schedule II prescriptions are permitted. DEA provides the following guidance on this topic and announces temporary exceptions. These exceptions shall remain in place for the duration of the Public Health Emergency (unless modified or withdrawn by DEA).

Read Full PDF >>